spectratox limited
spectratox limited Company Information
Company Number
SC328032
Next Accounts
Sep 2025
Shareholders
photobiology research & education trust (sc046167)
Group Structure
View All
Industry
General medical practice activities
Registered Address
kinburn castle, st andrews, fife, KY16 9DR
Website
www.spectratox.co.ukspectratox limited Estimated Valuation
Pomanda estimates the enterprise value of SPECTRATOX LIMITED at £79.3k based on a Turnover of £134.9k and 0.59x industry multiple (adjusted for size and gross margin).
spectratox limited Estimated Valuation
Pomanda estimates the enterprise value of SPECTRATOX LIMITED at £19.3k based on an EBITDA of £4.4k and a 4.36x industry multiple (adjusted for size and gross margin).
spectratox limited Estimated Valuation
Pomanda estimates the enterprise value of SPECTRATOX LIMITED at £66.9k based on Net Assets of £26.6k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Spectratox Limited Overview
Spectratox Limited is a live company located in fife, KY16 9DR with a Companies House number of SC328032. It operates in the general medical practice activities sector, SIC Code 86210. Founded in July 2007, it's largest shareholder is photobiology research & education trust (sc046167) with a 100% stake. Spectratox Limited is a established, micro sized company, Pomanda has estimated its turnover at £134.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Spectratox Limited Health Check
Pomanda's financial health check has awarded Spectratox Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £134.9k, make it smaller than the average company (£1.5m)
- Spectratox Limited
£1.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -18%, show it is growing at a slower rate (8.4%)
- Spectratox Limited
8.4% - Industry AVG
Production
with a gross margin of 47.6%, this company has a comparable cost of product (47.6%)
- Spectratox Limited
47.6% - Industry AVG
Profitability
an operating margin of 3.2% make it less profitable than the average company (5.6%)
- Spectratox Limited
5.6% - Industry AVG
Employees
with 3 employees, this is below the industry average (16)
3 - Spectratox Limited
16 - Industry AVG
Pay Structure
on an average salary of £38.6k, the company has an equivalent pay structure (£38.6k)
- Spectratox Limited
£38.6k - Industry AVG
Efficiency
resulting in sales per employee of £45k, this is less efficient (£93.4k)
- Spectratox Limited
£93.4k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (39 days)
- Spectratox Limited
39 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Spectratox Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Spectratox Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 705 weeks, this is more cash available to meet short term requirements (43 weeks)
705 weeks - Spectratox Limited
43 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 6.8%, this is a lower level of debt than the average (49.6%)
6.8% - Spectratox Limited
49.6% - Industry AVG
SPECTRATOX LIMITED financials
Spectratox Limited's latest turnover from December 2023 is estimated at £134.9 thousand and the company has net assets of £26.6 thousand. According to their latest financial statements, Spectratox Limited has 3 employees and maintains cash reserves of £26.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 128 | 255 | 382 | 641 | 263 | 475 | 1,919 | 2,976 | 7,764 | 12,892 | 11,852 | 14,881 | 2,998 | 1,821 | |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 128 | 255 | 382 | 641 | 263 | 475 | 1,919 | 2,976 | 7,764 | 12,892 | 11,852 | 14,881 | 2,998 | 1,821 | |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 2,054 | 1,284 | 314 | 39,279 | 192,654 | 1,503 | 91,384 | 1,382 | 1,528 | 889 | 21,806 | ||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 240 | 538 | 391 | 5,834 | 351 | ||||||||||
| Cash | 26,289 | 22,380 | 24,543 | 22,667 | 24,116 | 36,597 | 184,237 | 197,789 | 16,751 | 82,356 | 104,583 | 170,015 | 491,608 | ||
| misc current assets | 21,294 | 5,500 | |||||||||||||
| total current assets | 28,583 | 24,202 | 24,857 | 23,058 | 29,950 | 40,806 | 60,573 | 198,154 | 185,740 | 198,140 | 108,135 | 83,738 | 106,111 | 170,904 | 513,414 |
| total assets | 28,583 | 24,330 | 25,112 | 23,440 | 30,591 | 41,069 | 61,048 | 200,073 | 188,716 | 205,904 | 121,027 | 95,590 | 120,992 | 173,902 | 515,235 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 33 | 22 | 3,986 | 62,491 | 3,045 | 1,169 | 76,810 | 99,892 | 104,745 | 160,358 | 464,680 | ||||
| Group/Directors Accounts | 7,158 | ||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 1,939 | 1,875 | 1,550 | 1,312 | 1,405 | 39,873 | 61,307 | ||||||||
| total current liabilities | 1,939 | 1,875 | 1,550 | 1,312 | 1,438 | 1,844 | 3,986 | 62,491 | 50,076 | 62,476 | 76,810 | 99,892 | 104,745 | 160,358 | 464,680 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 1,939 | 1,875 | 1,550 | 1,312 | 1,438 | 1,844 | 3,986 | 62,491 | 50,076 | 62,476 | 76,810 | 99,892 | 104,745 | 160,358 | 464,680 |
| net assets | 26,644 | 22,455 | 23,562 | 22,128 | 29,153 | 39,225 | 57,062 | 137,582 | 138,640 | 143,428 | 44,217 | -4,302 | 16,247 | 13,544 | 50,555 |
| total shareholders funds | 26,644 | 22,455 | 23,562 | 22,128 | 29,153 | 39,225 | 57,062 | 137,582 | 138,640 | 143,428 | 44,217 | -4,302 | 16,247 | 13,544 | 50,555 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 128 | 127 | 127 | 259 | 259 | 4,788 | 5,128 | 5,505 | 4,408 | 4,132 | 930 | 720 | |||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 472 | 1,508 | -77 | -5,443 | -30,763 | -2,682 | -153,375 | 191,151 | 1,152 | -91,033 | 90,002 | -146 | 639 | -20,917 | 21,806 |
| Creditors | -33 | 11 | -3,964 | -58,505 | 59,446 | 1,876 | -75,641 | -23,082 | -4,853 | -55,613 | -304,322 | 464,680 | |||
| Accruals and Deferred Income | 64 | 325 | 238 | -93 | 1,405 | -39,873 | -21,434 | 61,307 | |||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -7,158 | 7,158 | |||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 3,909 | -2,163 | 1,876 | -1,449 | -12,481 | 36,597 | -184,237 | -13,552 | 181,038 | -65,605 | -22,227 | -65,432 | -321,593 | 491,608 | |
| overdraft | |||||||||||||||
| change in cash | 3,909 | -2,163 | 1,876 | -1,449 | -12,481 | 36,597 | -184,237 | -13,552 | 181,038 | -65,605 | -22,227 | -65,432 | -321,593 | 491,608 |
spectratox limited Credit Report and Business Information
Spectratox Limited Competitor Analysis
Perform a competitor analysis for spectratox limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in KY16 area or any other competitors across 12 key performance metrics.
spectratox limited Ownership
SPECTRATOX LIMITED group structure
Spectratox Limited has no subsidiary companies.
Ultimate parent company
PHOTOBIOLOGY TRUST
#0033302
1 parent
SPECTRATOX LIMITED
SC328032
spectratox limited directors
Spectratox Limited currently has 3 directors. The longest serving directors include Professor Sally Ibbotson (Feb 2017) and Dr Robert Dawe (Feb 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor Sally Ibbotson | 63 years | Feb 2017 | - | Director | |
| Dr Robert Dawe | Scotland | 57 years | Feb 2017 | - | Director |
| Dr Ewan Eadie | Scotland | 42 years | Mar 2021 | - | Director |
P&L
December 2023turnover
134.9k
+10%
operating profit
4.3k
0%
gross margin
47.6%
+6.06%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
26.6k
+0.19%
total assets
28.6k
+0.17%
cash
26.3k
+0.17%
net assets
Total assets minus all liabilities
Similar Companies
spectratox limited company details
company number
SC328032
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
July 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
kinburn (116) limited (October 2007)
accountant
JAMES HAIR & CO.
auditor
-
address
kinburn castle, st andrews, fife, KY16 9DR
Bank
BANK OF SCOTLAND
Legal Advisor
-
spectratox limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to spectratox limited.
spectratox limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SPECTRATOX LIMITED. This can take several minutes, an email will notify you when this has completed.
spectratox limited Companies House Filings - See Documents
| date | description | view/download |
|---|
